Early detection of Alzheimer's Disease is in the sights of University of Queensland (UQ) scientists who have secured $1.6 million for new research.
The UQ experts will work with peers at the Medical University of South Carolina to develop urgently-needed methods for early diagnosis of Alzheimer's Disease, which is the main form of dementia and afflicts more than 26 million people.
Queensland Premier Anna Bligh announced $808,000 from the National and International Research Alliances Program to support the three-year project, which has $810,000 in cash from the two universities.
Welcoming the June 18 announcement, UQ Vice-Chancellor Professor Paul Greenfield said the team would aim to develop Magnetic Resonance Imaging (MRI) biomarkers of Alzheimer's Disease.
“Alzheimer's Disease is known to be the most common cause of dementia, yet only about 60 percent of cases are diagnosed,” Professor Greenfield said.
“The new method will be non-invasive and will enable early diagnosis as well as safer monitoring of progression of the illness.
“The biomarkers would also be used to assess the efficacy of new and emerging drugs that aim to delay or arrest the advance of Alzheimer's Disease.”
Deputy Vice-Chancellor (Research) Professor David Siddle said early detection would have other important implications for patients, their families and carers.
“It will give them more time to plan their futures and to access resources,” Professor Siddle said.
Professor Greenfield and Professor Siddle congratulated the research team for its success in this hotly-contested funding round. The team involves UQ's Queensland Brain Institute, Centre for Magnetic Resonance, Centre for Integrated Preclinical Drug Development/TetraQ and Australian Institute for Bioengineering and Nanotechnology, as well as the Neuroscience Institute of the Medical University of South Carolina.
The researchers will use brain imaging equipment from both universities, which together are contributing $810,700 cash (excluding UQ salaries).
Source: The University of Queensland
Related stories:
Treating sleep apnea in Alzheimer's patients helps cognition
Continuous positive airway pressure (CPAP) treatment seems to improve cognitive functioning in patients with Alzheimer's disease who also suffer from obstructive sleep apnea, according to the results of a randomized clinical trial conducted at the University of California, San Diego. The study – led by Sonia Ancoli-Israel, Ph.D., professor of psychiatry at the UC San Diego School of Medicine and one of the nation's preeminent experts in the field of sleep disorders and sleep research in aging populations – was published in the November issue of the
Journal of the American Geriatric Society.
Common epilepsy drug could prevent and treat Alzheimer's disease
The team led by UBC Psychiatry Prof. Weihong Song, who is also the Jack Brown and Family Professor and Chair in Alzheimer's Disease at UBC, found that if Valproic Acid (VPA) is used as a treatment in early stages of AD memory deficit is reversed.
Scientists demonstrate means of reducing Alzheimer's-like plaques in fly brain
Neuroscientists at Cold Spring Harbor Laboratory (CSHL) are part of a collaboration that has succeeded in demonstrating that overexpression of an enzyme in the brain can reduce telltale deposits causally linked with Alzheimer's disease.
Study identifies toxic key to Alzheimer’s disease memory loss
Using new scientific techniques, scientists have unlocked the cascade of molecular events that lead to Alzheimer’s disease. The scientific findings published in the latest edition of Nature Medicine suggest a potential new target for the development of drug therapies to fight the irreversible and degenerative disease which affects some 29.8 million people worldwide. The total worldwide societal cost of dementia was estimated at somewhere in the region of US$315.4 billion in 2005.
Known Genetic Risk Alzheimer's In Whites Also Places Blacks At Risk
A commonly recognized gene that places one at risk for Alzheimer’s disease does not discriminate between blacks and whites, according to new research led by Florida State University.
Memory loss linked to common sleep disorder
For the first time, UCLA researchers have discovered that people with sleep apnea show tissue loss in brain regions that help store memory. Reported in the June 27 edition of the journal
Neuroscience Letters, the findings emphasize the importance of early detection of the disorder, which afflicts an estimated 20 million Americans.
Gene variation linked to earlier onset of Alzheimer's symptoms
Investigators at Washington University School of Medicine in St. Louis have identified a genetic variation associated with an earlier age of onset in Alzheimer's disease.
Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer’s disease, Huntington’s disease, epilepsy, stroke, dementia and malignant gliomas.